Articles

According to FutureWise analysis, the MRI pulse oximeters market in 2026 is US$35.13 million, and is expected to reach US$48.76 million by 2036 at a CAGR of 3.32%.  The MRI pulse oximeters market is currently experiencing notable growth, primarily due to the essential need for accurate oxygen saturation monitoring during MRI procedures, particularly for patients who are sedated or critically ill. These advanced devices utilize fiber-optic technology, which effectively mitigates electromagnetic interference, allowing for precise readings even within the high magnetic fields generated by MRI scanners. Several factors are driving this market expansion, including the rising prevalence of chronic respiratory diseases and an increasing number of pediatric and geriatric MRI scans that necessitate continuous monitoring. Hospitals and diagnostic imaging centers are the main end-users of these devices, highlighting the importance of patient safety protocols during extended imaging ... Continue reading →

According to FutureWise analysis, the MRI Safe Cardiac Resynchronization Therapy Device market in 2026 is US$0.84 billion, and is expected to reach US$1.75 billion by 2036 at a CAGR of 7.62%.  The market for MRI-safe Cardiac Resynchronization Therapy (CRT) devices is experiencing significant growth, largely due to the increasing prevalence of heart failure and the rising demand for patients with implanted cardiac devices to undergo MRI examinations for various medical conditions. The introduction of MRI-conditional CRT devices has addressed a crucial clinical gap, allowing patients to safely access this important diagnostic imaging without needing to have their devices removed. Technological advancements in lead design, pulse generator shielding, and filtering systems are enhancing the safety and performance of these devices within MRI environments. Additionally, the aging global population and the rising incidence of cardiovascular diseases are expanding the pool of patients who ... Continue reading →

According to FutureWise analysis, the MRI systems market in 2026 is US$7.83 billion, and is expected to reach US$12.06 billion by 2036 at a CAGR of 4.40% The MRI systems market is currently experiencing growth, primarily driven by the increasing prevalence of chronic diseases that necessitate advanced diagnostic imaging, along with the rising demand for early disease detection. Technological innovations, such as high-field MRI systems, open MRI configurations, and artificial intelligence-enhanced imaging, are improving both diagnostic accuracy and patient comfort. The applications of MRI are expanding across various medical specialties, including oncology, neurology, cardiology, and musculoskeletal disorders, which broadens the market's scope. Emerging markets in the Asia-Pacific region and Latin America are witnessing significant adoption of MRI technology, fueled by improvements in healthcare infrastructure and increasing healthcare spending. Furthermore, the shift toward ... Continue reading →

According to FutureWise analysis the market for MRI coils in 2026 is US$ 2.95 billion, and is expected to reach US$ 7.24 billion by 2036 at a CAGR of 9.39%. MRI coils are vital for magnetic resonance imaging, functioning as antennas that transmit and receive radiofrequency signals to produce high-resolution images. Innovations in coil design, including multi-channel and flexible options, improve image quality, patient comfort, and efficiency. The demand for advanced diagnostic imaging and rising chronic disease prevalence are driving market growth. Magnetic Resonance Imaging (MRI) coils are essential elements of MRI systems, playing a vital role in producing high-quality diagnostic images. Often known as radiofrequency (RF) coils, these devices function as antennas that transmit and receive electromagnetic signals during an MRI scan. When a patient is positioned inside an MRI scanner, the system generates a powerful magnetic field along with radiofrequency pulses. The MRI coils are ... Continue reading →

According to FutureWise analysis the market for mri compatible iv infusion pumps in 2026 is US$ 0.34 billion, and is expected to reach US$ 0.71 billion by 2036 at a CAGR of 7.64%. MRI-compatible IV infusion pumps are designed for safe use in MRI environments, allowing accurate delivery of fluids and medications during imaging. Made from non-ferromagnetic materials and shielded components, they ensure patient safety without compromising imaging quality. The growing need for continuous critical care during MRI scans, especially in intensive care and emergency settings, is driving market growth. Infusion pumps are vital medical devices designed to deliver fluids into a patient’s body with precise dosage control. They are commonly used to administer essential fluids, including nutrition and medications. Specifically, MRI-compatible IV infusion pumps enable the safe and accurate delivery of intravenous fluids during and after MRI scans. These pumps play a crucial role in providing ... Continue reading →

According to FutureWise analysis the market for MRI-guided Neurosurgical Ablation in 2026 is US$ 0.47 billion, and is expected to reach US$ 1.23 billion by 2036 at a CAGR of 10.10%. MRI-guided neurosurgical ablation is a minimally invasive procedure that utilizes real-time imaging to accurately target and destroy abnormal brain tissue, like tumors or epileptic foci. This method improves surgical precision, spares healthy tissue, and shortens recovery compared to traditional surgery. The market is expanding due to the rising use of image-guided therapies, the increasing prevalence of neurological disorders, and advancements in thermal ablation technologies. MRI-guided neurosurgical ablation is an innovative and minimally invasive technique designed to treat a range of neurological conditions by accurately targeting and eliminating abnormal brain tissue. This method uses real-time magnetic resonance imaging (MRI) to guide the procedure, enhancing the precision of treatment. Through the ... Continue reading →

According to FutureWise analysis, the Mucopolysaccharidosis Market in 2026 is US$3.27 billion, and is expected to reach US$6.19 billion by 2036 at a CAGR of 6.59%. Mucopolysaccharidosis (MPS) refers to a group of rare metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes known as glycosaminoglycan. This disorder leads to an inability to break down certain sugars in the body, resulting in the accumulation of compounds such as heparan sulfate, keratan sulfate, and dermatan sulfate, which interfere with the normal functioning of body cells. Severe neurological symptoms, including Sanfilippo syndrome and Hunter syndrome, are among the primary manifestations of mucopolysaccharidosis. Key players in the pharmaceutical industry are actively researching and developing advanced therapies to manage these symptoms. The increasing number of candidates from these key players in the rare disease therapeutic sector is expected to boost the growth of the ... Continue reading →

According to FutureWise analysis the market for MRI-guided Radiation Therapy Systems in 2026 is US$ 0.76 billion, and is expected to reach US$ 2.65 billion by 2036 at a CAGR of 13.30%. MRI-guided radiation therapy systems combine real-time MRI with linear accelerators to deliver precise radiation doses to tumors. This continuous visualization enables real-time treatment adjustments, improving targeting accuracy and reducing exposure to healthy tissues. Key factors driving market growth include rising demand for adaptive radiotherapy, increasing cancer incidence, and advancements in image-guided oncology solutions. MRI-guided Radiation Therapy Systems represent a significant advancement in oncology, merging high-resolution magnetic resonance imaging (MRI) with radiation delivery technology to improve the precision and efficacy of cancer treatment. These systems combine an MRI scanner with a linear accelerator (LINAC), allowing clinicians to visualize soft tissues in real time while ... Continue reading →

According to FutureWise analysis, the Mucormycosis market in 2026 is US$0.54 billion, and is expected to reach US$0.81 billion by 2036 at a CAGR of 4.14%.  The Mucormycosis market is experiencing growth due to an increased incidence of risk factors, such as uncontrolled diabetes, immunocompromised conditions, and a rising number of organ transplant recipients who require immunosuppressive therapy. The COVID-19 pandemic has underscored the vulnerability of certain patient populations to opportunistic fungal infections, leading to greater awareness and improved diagnostic capabilities. Antifungal agents, including formulations of amphotericin B, posaconazole, and isavuconazole, remain the cornerstone of treatment for this condition. Ongoing research is focused on developing novel therapeutic approaches. The high mortality rate associated with mucormycosis, along with the necessity for aggressive early intervention, is driving demand for effective treatment options and diagnostic ... Continue reading →

Gold has long been seen as a symbol of stability, reliability, and lasting wealth. From ancient civilizations to today’s global financial markets, it has consistently served as a safeguard against inflation and economic instability. Yet, investing in physical gold is not always simple. Challenges like secure storage, higher upfront costs, limited liquidity, and concerns about purity can make the process complicated. In a digital-first world, investors are increasingly seeking smarter and more convenient solutions. This is where Gold Tokenization is reshaping gold investment by blending the strength of physical gold with the efficiency of blockchain technology. Rather than buying and storing gold themselves, investors can own digital tokens that are backed by real gold kept in insured vaults. This approach preserves gold’s inherent value while delivering greater transparency, accessibility, and ease of management through digital ownership. How Gold Tokenization Works: A ... Continue reading →